See also this year's filing and all EDGAR filings for this company.
PDF Report 0001072379_2021_Northwest_Biotherapeutics_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - Calc 2': 2, '00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS': 12}} |
Graph
Absolute values for 0001072379, Northwest Biotherapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 15,511,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 626,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,040,000 |
| 3 | remainder_Assets | 15,722,000 |
| 4 | LiabilitiesCurrent | 382,424,000 |
| 5 | LiabilitiesNoncurrent | 13,423,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 25,290,975 |
| 9 | ResearchAndDevelopmentExpense | 48,734,381 |
| 10 | remainder_Expenses | 3,437,962 |
| 11 | remainder_Revenues | 1,507,504 |
| 12 | remainder_NetIncome | -400,251,368 |
| 13 | remainder_ComprehensiveNetIncome | -1,099,159 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 32,899,000 |
| 1 | Liabilities | 395,847,000 |
| 2 | Expenses | 77,463,318 |
| 3 | Revenues | 1,507,504 |
| 4 | StockholdersEquity | -362,948,000 |
| 5 | NetIncome | -476,207,182 |
| 6 | ComprehensiveNetIncome | -476,756,762 |
| 7 | BaseVar | 454,533,674 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -5.91 |
| 9 | EconomicCapitalRatio | 0.0859 |
Edgar->Model Mapping
Feature Distribution
Change over Time
